Induced Dopaminergic Neurons for Parkinson's Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?

Neurosci Bull. 2022 Jul;38(7):820-824. doi: 10.1007/s12264-022-00829-6. Epub 2022 Feb 23.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Corpus Striatum
  • Dopaminergic Neurons
  • Humans
  • Mesencephalon
  • Parkinson Disease* / drug therapy
  • Pars Compacta*
  • Substantia Nigra